Article thumbnail
Location of Repository

Rosiglitazone as a therapeutic agent to reduce inflammatory risk in type 2 diabetic patients

By A. L. (Alison L.) Harte, Nasser M. Al-Daghri, Khalid Al-Rubeaan, Omar S. Al-Attas, N. F. da Silva, Shaun Sabico, Sudhesh Kumar and P. G. (Philip G.) McTernan
Topics: RC
Publisher: Springer
Year: 2007
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.